Sarepta Therapeutics (SRPT)
(Delayed Data from NSDQ)
$117.12 USD
+2.13 (1.85%)
Updated Apr 23, 2024 04:00 PM ET
After-Market: $117.12 0.00 (0.00%) 7:58 PM ET
2-Buy of 5 2
D Value B Growth C Momentum C VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 5/7/24 |
---|---|
Current Quarter | -0.62 |
EPS Last Quarter | 0.47 |
Last EPS Surprise | 1,666.67% |
ABR | 1.50 |
Earnings ESP
|
104.86% |
---|---|
Current Year | 2.13 |
Next Year | 7.96 |
EPS (TTM) | -1.23 |
P/E (F1) | 54.84 |
Sales Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 370.74M | 380.45M | 1.81B | 2.73B |
# of Estimates | 8 | 8 | 8 | 8 |
High Estimate | 402.31M | 415.37M | 2.37B | 4.06B |
Low Estimate | 299.50M | 286.50M | 1.51B | 1.67B |
Year ago Sales | 253.50M | 261.24M | 1.24B | 1.81B |
Year over Year Growth Est. | 46.25% | 45.63% | 45.96% | 50.35% |
Earnings Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.62 | 0.17 | 2.13 | 7.96 |
# of Estimates | 8 | 5 | 7 | 8 |
Most Recent Consensus | -0.35 | 0.04 | 6.66 | 14.91 |
High Estimate | 0.13 | 1.02 | 6.66 | 17.69 |
Low Estimate | -4.06 | -0.47 | -0.60 | -1.64 |
Year ago EPS | -0.97 | -0.27 | -5.80 | 2.13 |
Year over Year Growth Est. | 36.08% | 162.96% | 136.72% | 273.52% |
Agreement - Estimate Revisions
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 2 | 1 | 3 | 2 |
Down Last 7 Days | 0 | 0 | 1 | 1 |
Down Last 30 Days | 1 | 0 | 1 | 1 |
Down Last 60 Days | 3 | 3 | 4 | 4 |
Magnitude - Consensus Estimate Trend
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.62 | 0.17 | 2.13 | 7.96 |
7 Days Ago | -0.62 | 0.17 | 2.14 | 8.10 |
30 Days Ago | -0.57 | 0.13 | 1.94 | 8.22 |
60 Days Ago | -0.78 | 0.42 | 1.51 | 6.75 |
90 Days Ago | -0.01 | 0.45 | 2.44 | 9.10 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | 0.03 | 0.17 | 6.66 | 14.91 |
Zacks Consensus Estimate | -0.62 | 0.17 | 2.13 | 7.96 |
Earnings ESP | 104.86% | 0.00% | 212.25% | 87.34% |
Surprise - Reported Earnings History
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Quarter Ending (3/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | 0.47 | -0.46 | -0.27 | -0.97 | NA |
Estimate | -0.03 | -1.66 | -1.89 | -1.46 | NA |
Difference | 0.50 | 1.20 | 1.62 | 0.49 | 0.95 |
Surprise | 1,666.67% | 72.29% | 85.71% | 33.56% | 464.56% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more